Equities analysts forecast that McKesson Co. (NYSE:MCK) will announce earnings of $4.11 per share for the current fiscal quarter, Zacks reports. Five analysts have provided estimates for McKesson’s earnings. The lowest EPS estimate is $4.06 and the highest is $4.18. McKesson reported earnings of $3.69 per share in the same quarter last year, which indicates a positive year over year growth rate of 11.4%. The company is scheduled to report its next quarterly earnings report on Wednesday, May 13th.
According to Zacks, analysts expect that McKesson will report full-year earnings of $14.79 per share for the current fiscal year, with EPS estimates ranging from $14.70 to $14.90. For the next year, analysts anticipate that the company will post earnings of $15.86 per share, with EPS estimates ranging from $15.64 to $16.00. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side research analysts that follow McKesson.
McKesson (NYSE:MCK) last released its quarterly earnings results on Tuesday, February 4th. The company reported $3.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.56 by $0.25. McKesson had a positive return on equity of 36.40% and a negative net margin of 0.41%. The business had revenue of $59.17 billion during the quarter, compared to analyst estimates of $59.10 billion. During the same quarter last year, the company posted $3.40 EPS. McKesson’s revenue for the quarter was up 5.3% on a year-over-year basis.
Shares of NYSE MCK traded down $5.07 during trading on Wednesday, reaching $121.24. The company had a trading volume of 2,491,271 shares, compared to its average volume of 5,237,874. McKesson has a 52 week low of $111.71 and a 52 week high of $172.18. The business’s 50 day moving average price is $148.47 and its 200-day moving average price is $144.35. The stock has a market cap of $20.48 billion, a PE ratio of -24.79, a PEG ratio of 1.27 and a beta of 1.03. The company has a debt-to-equity ratio of 1.33, a quick ratio of 0.56 and a current ratio of 0.98.
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be issued a $0.41 dividend. The ex-dividend date is Friday, February 28th. This represents a $1.64 annualized dividend and a dividend yield of 1.35%. McKesson’s dividend payout ratio (DPR) is currently 12.09%.
In related news, CEO Brian S. Tyler sold 4,063 shares of the stock in a transaction that occurred on Monday, March 16th. The stock was sold at an average price of $124.77, for a total transaction of $506,940.51. Following the completion of the sale, the chief executive officer now directly owns 16,255 shares of the company’s stock, valued at approximately $2,028,136.35. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Brian S. Tyler sold 4,062 shares of the stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $167.09, for a total value of $678,719.58. Following the sale, the chief executive officer now directly owns 16,254 shares of the company’s stock, valued at $2,715,880.86. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 12,187 shares of company stock worth $1,809,908. 0.88% of the stock is currently owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in MCK. CSat Investment Advisory L.P. boosted its holdings in McKesson by 19.7% in the fourth quarter. CSat Investment Advisory L.P. now owns 364 shares of the company’s stock valued at $50,000 after acquiring an additional 60 shares during the last quarter. We Are One Seven LLC grew its stake in shares of McKesson by 0.6% in the fourth quarter. We Are One Seven LLC now owns 11,131 shares of the company’s stock worth $1,539,000 after purchasing an additional 64 shares during the last quarter. Penserra Capital Management LLC grew its stake in shares of McKesson by 55.6% in the fourth quarter. Penserra Capital Management LLC now owns 210 shares of the company’s stock worth $30,000 after purchasing an additional 75 shares during the last quarter. DAVENPORT & Co LLC increased its holdings in McKesson by 4.0% during the 4th quarter. DAVENPORT & Co LLC now owns 2,189 shares of the company’s stock valued at $303,000 after purchasing an additional 85 shares during the period. Finally, Hi Line Capital Management LLC increased its holdings in McKesson by 0.3% during the 4th quarter. Hi Line Capital Management LLC now owns 35,786 shares of the company’s stock valued at $4,950,000 after purchasing an additional 90 shares during the period. 88.20% of the stock is currently owned by hedge funds and other institutional investors.
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
See Also: Equity Income
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.